Los Angeles Capital Management LLC Has $5.01 Million Stock Holdings in Encompass Health Co. (NYSE:EHC)

Los Angeles Capital Management LLC lifted its stake in shares of Encompass Health Co. (NYSE:EHC - Free Report) by 7.8% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 54,213 shares of the company's stock after purchasing an additional 3,923 shares during the period. Los Angeles Capital Management LLC owned approximately 0.05% of Encompass Health worth $5,007,000 at the end of the most recent quarter.

Several other hedge funds have also modified their holdings of the stock. Point72 Asset Management L.P. grew its position in Encompass Health by 2,458.5% during the 3rd quarter. Point72 Asset Management L.P. now owns 869,104 shares of the company's stock worth $83,990,000 after purchasing an additional 835,135 shares in the last quarter. Jennison Associates LLC purchased a new position in shares of Encompass Health during the fourth quarter valued at $52,094,000. abrdn plc purchased a new stake in Encompass Health in the 4th quarter worth about $17,846,000. Thrivent Financial for Lutherans lifted its stake in Encompass Health by 26.0% in the 3rd quarter. Thrivent Financial for Lutherans now owns 760,496 shares of the company's stock worth $73,494,000 after acquiring an additional 156,938 shares in the last quarter. Finally, Franklin Resources Inc. boosted its position in Encompass Health by 22.0% during the 3rd quarter. Franklin Resources Inc. now owns 700,021 shares of the company's stock worth $67,412,000 after acquiring an additional 126,000 shares during the period. 97.25% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on the stock. StockNews.com raised shares of Encompass Health from a "hold" rating to a "buy" rating in a research report on Saturday, February 15th. KeyCorp boosted their price target on shares of Encompass Health from $117.00 to $120.00 and gave the company an "overweight" rating in a report on Monday, February 10th. William Blair reiterated an "outperform" rating on shares of Encompass Health in a report on Friday, February 7th. Royal Bank of Canada reaffirmed an "outperform" rating and issued a $110.00 target price on shares of Encompass Health in a research report on Tuesday, February 11th. Finally, Barclays lifted their price target on Encompass Health from $116.00 to $118.00 and gave the company an "overweight" rating in a report on Friday, February 7th. Ten analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, the company presently has an average rating of "Buy" and a consensus target price of $107.67.

Remove Ads

Insider Buying and Selling

In other Encompass Health news, CAO Andrew L. Price sold 5,042 shares of Encompass Health stock in a transaction on Thursday, February 13th. The shares were sold at an average price of $98.29, for a total transaction of $495,578.18. Following the sale, the chief accounting officer now owns 69,164 shares in the company, valued at $6,798,129.56. The trade was a 6.79 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 2.10% of the stock is owned by company insiders.

Encompass Health Stock Performance

Shares of NYSE EHC traded down $0.41 during trading hours on Monday, hitting $99.73. 681,585 shares of the stock were exchanged, compared to its average volume of 658,644. Encompass Health Co. has a one year low of $74.27 and a one year high of $104.55. The company's 50 day moving average is $96.42 and its 200 day moving average is $96.42. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.05 and a quick ratio of 1.04. The firm has a market capitalization of $10.05 billion, a P/E ratio of 22.36, a P/E/G ratio of 2.31 and a beta of 0.90.

Encompass Health (NYSE:EHC - Get Free Report) last issued its quarterly earnings results on Thursday, February 6th. The company reported $1.17 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.05 by $0.12. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. On average, research analysts expect that Encompass Health Co. will post 4.8 EPS for the current year.

Encompass Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, April 17th. Stockholders of record on Tuesday, April 1st will be given a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.68%. The ex-dividend date of this dividend is Tuesday, April 1st. Encompass Health's dividend payout ratio is currently 15.25%.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.